Search results for "Edema"

showing 10 items of 625 documents

Evolution of brain abscess in cats formation of capsule and resolution of brain edema

1980

Brain abscess evolution was studied in an experimental model in the cat correlating the computed tomographic scan appearance with intracranial pressure, brain edema and histopathological findings. Brain inflammation was produced by direct inoculation of Staphylococcus aureus into the white matter. Abscesses developed in all animals. The ring enhancement around the necrotic focus seen at an early stage after contrast-medium injection cannot be equated with capsule formation as long as the abscess diameter increased. Parallel to the acute stage of abscess, the intraventricular pressure increased due to the rising mass effect and the spreading edma. The morphological investigations revealed on…

MalePathologymedicine.medical_specialtyIntracranial PressureBrain AbscessBrain EdemaWhite matterEdemaAnimalsMedicineAbscessBrain abscessIntracranial pressureCATSbusiness.industryCapsuleGeneral MedicineStaphylococcal Infectionsmedicine.diseaseDisease Models AnimalMicroscopy Electronmedicine.anatomical_structureCatsFemaleSurgeryNeurology (clinical)Neurosurgerymedicine.symptomTomography X-Ray ComputedbusinessNeurosurgical Review
researchProduct

Moderate controlled cortical contusion in pigs: effects on multi-parametric neuromonitoring and clinical relevance.

2004

Over the last decade, routine neuromonitoring of ICP and CPP has been extended with new on-line techniques such as microdialysis, tissue oxygen (ptiO(2)), acid-base balance (ptiCO(2), pH) and CBF measurements, which so far have not lead to clear-cut therapy approaches in the neurointensive care unit. This is partially due to the complex pathophysiology following a wide-range of brain injuries, and the lack of suitable animal models allowing simultaneous, clinically relevant neuromonitoring under controlled conditions. Therefore, a controlled cortical impact (CCI) model in large animals (pig) has been developed. After placement of microdialysis, ptiO(2), temperature and ICP catheters, an uni…

MalePathologymedicine.medical_specialtyMicrodialysisIntracranial PressureSwineGlutamic AcidBrain EdemaBody TemperatureCentral nervous system diseaseText miningOxygen ConsumptionPyruvic AcidmedicineAnimalsClinical significanceLactic AcidCell damageMonitoring Physiologicbusiness.industryGlutamate receptormedicine.diseasePathophysiologyDisease Models Animalmedicine.anatomical_structureGlucoseCerebral cortexAnesthesiaBrain InjuriesNeurology (clinical)businessJournal of neurotrauma
researchProduct

Increased Expression of AQP 1 and AQP 5 in Rat Lungs Ventilated with Low Tidal Volume is Time Dependent

2014

BACKGROUND AND GOALS: Mechanical ventilation (MV) can induce or worsen pulmonary oedema. Aquaporins (AQPs) facilitate the selective and rapid bi-directional movement of water. Their role in the development and resolution of pulmonary oedema is controversial. Our objectives are to determine if prolonged MV causes lung oedema and changes in the expression of AQP 1 and AQP 5 in rats. METHODS: 25 male Wistar rats were subjected to MV with a tidal volume of 10 ml/kg, during 2 hours (n = 12) and 4 hours (n = 13). Degree of oedema was compared with a group of non-ventilated rats (n = 5). The expression of AQP 1 and AQP 5 were determined by western immunoblotting, measuring the amount of mRNA (prev…

MalePathologymedicine.medical_specialtyPhysiologymedicine.medical_treatmentlcsh:MedicineAquaporinPulmonary EdemaVascular permeabilityCapillary PermeabilityRespirationTidal VolumeMedicine and Health SciencesAnimalsMedicineRespiratory PhysiologyRats Wistarlcsh:ScienceLungTidal volumeMechanical ventilationMultidisciplinaryLungAquaporin 1business.industrylcsh:RHemodynamicsBiology and Life SciencesPulmonary edemamedicine.diseaseRespiration ArtificialAquaporin 5RatsOxygenmedicine.anatomical_structureGene Expression RegulationAquaporin 1lcsh:QbusinessResearch ArticlePLoS ONE
researchProduct

Cutaneous complications of Anderson-Fabry disease.

2013

Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by a defect in the -galactosidase A gene, which leads to the deficiency of the hydrolytic enzyme -galactosidase A. The consequent inability to catabolize glycosphingolipids causes progressive accumulation of globotriaosylceramide in the vascular endothelium throughout the body. Fatalities in the classical phenotype may usually occur as a consequence of cerebral, cardiac or renal disease. Dermatological manifestations are a relevant feature of Fabry disease and include angiokeratomas, telangiectasiae, lymphedema, anhidrosis or hypohidrosis and pseudo-acromegalic facial appearance. The actual causal treatment for Fabry …

MalePathologymedicine.medical_specialtySkin NeoplasmsGlobotriaosylceramideDiseaseDiagnosis Differentialchemistry.chemical_compoundDrug DiscoverymedicineHumansAge FactorEnzyme Replacement TherapySkin NeoplasmAnhidrosisSkinPharmacologySex CharacteristicsVascular diseasebusiness.industryAge FactorsEnzyme replacement therapySex Characteristicmedicine.diseaseFabry diseaseAngiokeratomaLymphedemachemistryalpha-GalactosidaseFabry DiseaseFemalemedicine.symptombusinessHumanAngiokeratomaCurrent pharmaceutical design
researchProduct

Time sequence and site of fluid accumulation in experimental neurogenic pulmonary edema.

1976

The initial phase of pulmonary edema development following intracranial pressure elevation was studied by means of transmission electron microscopy. Using perfusion fixation and application of a blood tracer (HRP horseradish peroxidase) the time sequence and site of fluid leakage out of pulmonary vessels was demonstrated: - passage of edema fluid through intercellular clefts of alveolar capillary endothelium - edema accumulation in alveolar interstitial tissue - draining of edema fluid from the alveolar septum to the interstitium of terminal bronchioli and to lymphatic vessels. An early interepithelial fluid leakage out of the alveolar wall remains questionable.

MalePathologymedicine.medical_specialtyTime FactorsIntracranial PressurePulmonary EdemaHorseradish peroxidaseCapillary PermeabilityEdemamedicineAnimalsCraniocerebral TraumaLungHorseradish PeroxidaseFixation (histology)Alveolar WallbiologyChemistryAlveolar septumGeneral MedicineAnatomyrespiratory systemPulmonary edemamedicine.diseaseCapillariesRatsPulmonary AlveoliMicroscopy ElectronLymphatic systemIntercellular Junctionsbiology.proteinmedicine.symptomPerfusionResearch in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
researchProduct

Photodynamic therapy within edematous brain tissue: Considerations on sensitizer dose and time point of laser irradiation

1996

Photosensitizer is known to spread with vasogenic edema fluid arising from a cerebral lesion (Neurosurg 33:1075-1082, 1993), which may be essential for sensitizing malignant cells outside the main tumor mass. The present experiments seek to elucidate whether resultant necrosis of perifocal brain tissue after laser irradiation follows a corresponding time pattern and whether damage depends on the photosensitizer dose. Male Wistar rats were anaesthetized with chloralhydrate for venous cannulation, craniotomy and focal cold lesion in order to induce vasogenic edema. Simultaneously, Photofrin II (PF II) was administered at a dose of 5 mg kg-1. The animals were re-anaesthetized after either 4, 1…

MalePathologymedicine.medical_specialtyTime FactorsNecrosismedicine.medical_treatmentBiophysicsBrain EdemaPhotodynamic therapyBlood–brain barrierLesionmedicineAnimalsRadiology Nuclear Medicine and imagingPhotosensitizerRats WistarCraniotomySensitizationRadiationDose-Response Relationship DrugRadiological and Ultrasound TechnologyBrain NeoplasmsChemistryRatsmedicine.anatomical_structurePhotochemotherapyDihematoporphyrin EtherLaser Therapymedicine.symptomPerfusionJournal of Photochemistry and Photobiology B: Biology
researchProduct

Kinetics of Photofrin II in perifocal brain edema.

1993

Photodynamic therapy is under intense investigation as a possible adjuvant for the treatment of malignant tumors of the central nervous system. It relies on the fact that photosensitizers are selectively taken up or retained by malignant tissue. However, most brain tumors are accompanied by substantial vasogenic edema as a consequence of blood-brain barrier disruption within the tumor, leading to extravasation and propagation of plasma constituents into the surrounding brain tissue. Systemically administered photosensitizers may enter healthy tissue together with the edema fluid, possibly leading to sensitization of tissues outside the tumor. To test this hypothesis, vasogenic edema was ind…

MalePathologymedicine.medical_specialtymedicine.medical_treatmentCentral nervous systemPhotodynamic therapyBrain EdemaCerebral edemaLesionchemistry.chemical_compoundEdemamedicineAnimalsPhotosensitizerTissue DistributionRats WistarFluorescein isothiocyanatebusiness.industryBrain Neoplasmsmedicine.diseaseExtravasationRatsCold TemperatureDisease Models Animalmedicine.anatomical_structurechemistryMicroscopy FluorescencePhotochemotherapySurgeryDihematoporphyrin EtherNeurology (clinical)medicine.symptombusinessFluorescein-5-isothiocyanateExtravasation of Diagnostic and Therapeutic MaterialsNeurosurgery
researchProduct

WAO guideline for the management of hereditary angioedema

2012

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we convened a group of specialists that focus upon HAE from around the world to develop not only a consensus on diagnosis and management of HAE, but to also provide evidence based grades, strength of evidence and classification for the consensus. Since both consensus and evidence grading were adhered to the document meets criteria as a guideline. The outcome of the guideline is to improve diagnosis and management of patients with HAE throughout the world and to help initiate uniform care …

MalePediatricsdiagnosisInternational CooperationAlternative medicinePatient Care PlanningHereditary AngioedemaEcallantidemedicationsPregnancyBradykinin B2 Receptor AntagonistsHealth careWAO GuidelineImmunology and AllergyChildEvidence-Based MedicineRecombinant ProteinsChild PreschoolinternationalPractice Guidelines as TopicHereditary angioedemaFemaleKallikreinsComplement C1 Inhibitor Proteinmanagementmedicine.drugPulmonary and Respiratory Medicinelcsh:Immunologic diseases. Allergymedicine.medical_specialtyEvidence-based practiceImmunologyMEDLINEGuidelinesDiagnosis DifferentialAllergy and ImmunologymedicineHumansddc:610Intensive care medicinetherapybusiness.industryDanazolAngioedemas HereditaryHAESocial SupportGuidelinemedicine.diseasePeptidesbusinesslcsh:RC581-607Rare disease
researchProduct

Inhibition of Proteasomal Glucocorticoid Receptor Degradation Restores Dexamethasone-Mediated Stabilization of the Blood–Brain Barrier After Traumati…

2013

To establish the molecular background for glucocorticoid insensitivity, that is, failure to reduce edema formation and to protect blood-brain barrier integrity after acute traumatic brain injury.Controlled animal study.University research laboratory.Male C57Bl/6N mice.Mechanical brain lesion by controlled cortical impact.Our study demonstrates that 1) proteasomal glucocorticoid receptor degradation is established in brain endothelial cells after traumatic brain injury as a form of posttranslational glucocorticoid receptor modification; 2) inhibition of the proteasomal degradation pathway with bortezomib (0.2 mg/kg) in combination with the glucocorticoid dexamethasone (10 mg/kg) by subcutane…

MaleProteasome Endopeptidase ComplexTraumatic brain injuryBlotting WesternBrain EdemaPharmacologyReal-Time Polymerase Chain ReactionCritical Care and Intensive Care MedicineBlood–brain barrierSensitivity and SpecificityDexamethasoneStatistics NonparametricBortezomibMiceRandom AllocationReceptors GlucocorticoidGlucocorticoid receptorReference ValuesmedicineAnimalsRNA MessengerReceptorDexamethasonebusiness.industryBortezomibmedicine.diseaseBoronic AcidsImmunohistochemistryMice Inbred C57BLBlotDisease Models Animalmedicine.anatomical_structureBlood-Brain BarrierBrain InjuriesPyrazinesMultivariate AnalysisBlood Gas AnalysisbusinessGlucocorticoidmedicine.drugCritical Care Medicine
researchProduct

Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases

2019

Abstract Hypoxic pulmonary vasoconstriction (HPV) is a well-characterized vascular response to low oxygen pressures and is involved in life-threatening conditions such as high-altitude pulmonary edema (HAPE) and pulmonary arterial hypertension (PAH). While the efficacy of oral therapies can be affected by drug metabolism, or dose-limiting systemic toxicity, inhaled treatment via pressured metered dose inhalers (pMDI) may be an effective, nontoxic, practical alternative. We hypothesized that a stable water-in-perfluorooctyl bromide (PFOB) emulsion that provides solubility in common pMDI propellants, engineered for intrapulmonary delivery of pulmonary vasodilators, reverses HPV during acute h…

MalePulmonary CirculationDrug Evaluation PreclinicalPharmaceutical Science02 engineering and technologyPharmacology030226 pharmacology & pharmacyRats Sprague-DawleyDrug Delivery Systems0302 clinical medicineHypoxic pulmonary vasoconstrictionHigh-altitude pulmonary edemapulmonary hypertensionMedicineFluorocarbonsPhenylpropionatesmedicine.diagnostic_testGeneral Medicine021001 nanoscience & nanotechnologyPulmonary edema3. Good healthPyridazinesTreatment Outcomemedicine.anatomical_structureEmulsions0210 nano-technologyendothelinResearch Articlemedicine.drugpulmonary pressuresAmbrisentanambrisentanHypertension PulmonaryPulmonary Edema03 medical and health sciencesmedicine.arteryAnimalsAntihypertensive AgentsLungsodium nitriteperfluorocarbonbusiness.industrylcsh:RM1-950Watermedicine.diseasePulmonary hypertensionRatsBronchoalveolar lavagelcsh:Therapeutics. PharmacologyPulmonary arteryhigh altitude pulmonary edemabusinessDrug Delivery
researchProduct